000 01323 a2200313 4500
005 20250514201640.0
264 0 _c20050804
008 200508s 0 0 eng d
022 _a1173-8804
024 7 _a10.2165/00063030-200418050-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNanji, Sulaiman A
245 0 0 _aIslet transplantation in patients with diabetes mellitus: choice of immunosuppression.
_h[electronic resource]
260 _bBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
_c2004
300 _a315-28 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCanada
650 0 4 _aClinical Protocols
_xstandards
650 0 4 _aClinical Trials as Topic
650 0 4 _aDiabetes Mellitus
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
_xmethods
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aIslets of Langerhans Transplantation
_xmethods
650 0 4 _aTransplantation Tolerance
_xdrug effects
700 1 _aShapiro, A M James
773 0 _tBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
_gvol. 18
_gno. 5
_gp. 315-28
856 4 0 _uhttps://doi.org/10.2165/00063030-200418050-00004
_zAvailable from publisher's website
999 _c15070540
_d15070540